Fruquintinib: a novel antivascular endothelial growth factor receptor tyrosine kinase inhibitor for the treatment of metastatic colorectal cancer

Zhang Y, Zou JY, Wang Z, Wang Y

Cancer Management and Research 2019, 11:7787-7803

Published Date: 16 August 2019